Erasca, Inc.
A clinical-stage oncology company developing therapies for RAS/MAPK pathway-driven cancers.
ERAS | US
Overview
Corporate Details
- ISIN(s):
- US29479A1088
- LEI:
- Country:
- United States of America
- Address:
- 3115 MERRYFIELD ROW, 92121 SAN DIEGO
- Website:
- https://www.erasca.com/
- Sector:
- Manufacturing
Description
Erasca, Inc. is a clinical-stage precision oncology company with the mission to erase cancer. The company focuses on discovering, developing, and commercializing therapies for patients with cancers driven by mutations in the RAS/MAPK pathway, one of the most frequently altered signaling cascades in human tumors. Erasca is advancing a robust, modality-agnostic portfolio of therapeutic programs purposefully built to comprehensively target and shut down this pathway. This approach aims to address significant unmet medical needs and provide transformative treatments for a wide range of cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Erasca, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Erasca, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Erasca, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
